Caitlin Zebley is an Oncology physician affiliated with St. Jude Children's Research Hospital. OpenAlex indexes 56 publications with 1,877 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TerSera Therapeutics LLCProgram year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth”
St. Jude Children'S Research Hospital
FY2026$263,778K08CA279926 - Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth”
St. Jude Children'S Research Hospital
FY2025$263,778K08CA279926 - Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth”
St. Jude Children'S Research Hospital
FY2023$263,778K08CA279926
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patients
Blood Immunology & Cellular Therapy
2025 - DNA hypomethylating agents can reverse terminal T cell differentiation 2186
The Journal of Immunology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Amar Gajjar, MD
St. Jude Children's Research Hospital
Thomas Merchant, DO
St. Jude Children's Research Hospital
Alberto Pappo, MD
St. Jude Children's Research Hospital
Gregory Armstrong, MD
St. Jude Children's Research Hospital
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”